Effects of telmisartan on hypertensive patients with dyslipidemia and insulin resistance

查看全文 作　　者：Olabode [1]Oladeinde 机构地区：[1]Consultant Department of Medicine,St. Mary Medical Center and Community Healthcare Systems. Program Director,Pinnacle Healthcare Systems. Medical Director,Northwest Indiana Medical Consultants PC. Assistant Professor of Medicine,Indiana University School of Medicine,Northwest. 出　　处：《Journal of Geriatric Cardiology》索引2007年第4卷第3期,共2页 摘　　要：The benefits of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) beyond blood pressure reduction have been proven through many large studies (HOPE, LIFE) in high risk CVD patients;1 post hoc studies have shown reductions in new onset type 2 diabetes mellitus (DM). …… 关 键 词：high CVD Effects of telmisartan on hypertensive patients with dyslipidemia and insulin resistance ARB IFG